KORU Medical Systems, Inc. (KRMD)
USD 3.7
(-10.19%)
USD 3.7
(-10.19%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 26.1 Million USD | -0.16% |
| 2022 | 26.14 Million USD | 25.73% |
| 2021 | 20.79 Million USD | 51.34% |
| 2020 | 13.74 Million USD | 26.64% |
| 2019 | 10.85 Million USD | 24.07% |
| 2018 | 8.74 Million USD | 9.69% |
| 2017 | 7.97 Million USD | -3.99% |
| 2016 | 8.3 Million USD | 29.34% |
| 2015 | 6.42 Million USD | 15.91% |
| 2014 | 5.54 Million USD | 28.77% |
| 2013 | 4.3 Million USD | 10.82% |
| 2012 | 3.88 Million USD | 36.23% |
| 2011 | 2.84 Million USD | 37.77% |
| 2010 | 2.06 Million USD | 15.57% |
| 2009 | 1.78 Million USD | 26.35% |
| 2008 | 1.41 Million USD | 12.96% |
| 2007 | 1.25 Million USD | 14.73% |
| 2006 | 1.09 Million USD | -1.12% |
| 2005 | 1.1 Million USD | -7.34% |
| 2004 | 1.19 Million USD | 13.58% |
| 2003 | 1.05 Million USD | 10.63% |
| 2002 | 949.57 Thousand USD | 18.37% |
| 2001 | 802.2 Thousand USD | -25.81% |
| 2000 | 1.08 Million USD | -8.15% |
| 1999 | 1.17 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 6.45 Million USD | -5.55% |
| 2024 Q1 | 6.83 Million USD | 8.46% |
| 2023 FY | 26.1 Million USD | -0.16% |
| 2023 Q3 | 6.13 Million USD | -13.77% |
| 2023 Q2 | 7.11 Million USD | -1.27% |
| 2023 Q4 | 6.3 Million USD | 2.72% |
| 2023 Q1 | 7.2 Million USD | 9.32% |
| 2022 Q4 | 6.58 Million USD | 12.61% |
| 2022 Q2 | 6.95 Million USD | 3.12% |
| 2022 Q3 | 5.85 Million USD | -15.92% |
| 2022 Q1 | 6.74 Million USD | 13.52% |
| 2022 FY | 26.14 Million USD | 25.73% |
| 2021 FY | 20.79 Million USD | 51.34% |
| 2021 Q1 | 5.44 Million USD | 57.32% |
| 2021 Q2 | 4.59 Million USD | -15.68% |
| 2021 Q4 | 5.94 Million USD | 23.4% |
| 2021 Q3 | 4.81 Million USD | 4.93% |
| 2020 FY | 13.74 Million USD | 26.64% |
| 2020 Q3 | 3.58 Million USD | -0.38% |
| 2020 Q4 | 3.46 Million USD | -3.35% |
| 2020 Q1 | 3.2 Million USD | 1.03% |
| 2020 Q2 | 3.59 Million USD | 12.15% |
| 2019 Q4 | 3.17 Million USD | 17.75% |
| 2019 FY | 10.85 Million USD | 24.07% |
| 2019 Q3 | 2.69 Million USD | 16.4% |
| 2019 Q2 | 2.31 Million USD | -13.32% |
| 2019 Q1 | 2.67 Million USD | -15.22% |
| 2018 Q3 | 2.12 Million USD | -0.01% |
| 2018 FY | 8.74 Million USD | 9.69% |
| 2018 Q4 | 3.14 Million USD | 48.41% |
| 2018 Q1 | 1.96 Million USD | -13.59% |
| 2018 Q2 | 2.12 Million USD | 8.04% |
| 2017 Q4 | 2.27 Million USD | 14.47% |
| 2017 Q2 | 2.1 Million USD | 20.44% |
| 2017 Q1 | 1.74 Million USD | -19.62% |
| 2017 FY | 7.97 Million USD | -3.99% |
| 2017 Q3 | 1.98 Million USD | -5.73% |
| 2016 FY | 8.3 Million USD | 29.34% |
| 2016 Q1 | 1.5 Million USD | -17.22% |
| 2016 Q4 | 2.17 Million USD | 4.96% |
| 2016 Q3 | 2.07 Million USD | -10.1% |
| 2016 Q2 | 2.3 Million USD | 53.17% |
| 2015 Q4 | 1.81 Million USD | 21.28% |
| 2015 Q3 | 1.49 Million USD | -6.06% |
| 2015 Q2 | 1.59 Million USD | 7.01% |
| 2015 Q1 | 1.49 Million USD | 3.22% |
| 2015 FY | 6.42 Million USD | 15.91% |
| 2014 Q3 | 1.31 Million USD | 2.52% |
| 2014 Q4 | 1.44 Million USD | 9.72% |
| 2014 FY | 5.54 Million USD | 28.77% |
| 2014 Q1 | 1.1 Million USD | 2.3% |
| 2014 Q2 | 1.28 Million USD | 15.83% |
| 2013 Q4 | 1.08 Million USD | 1.89% |
| 2013 Q2 | 1.04 Million USD | 6.71% |
| 2013 FY | 4.3 Million USD | 10.82% |
| 2013 Q1 | 978.25 Thousand USD | -18.49% |
| 2013 Q3 | 1.06 Million USD | 1.98% |
| 2012 Q2 | 960.68 Thousand USD | 12.73% |
| 2012 Q4 | 1.2 Million USD | 61.44% |
| 2012 Q3 | 743.38 Thousand USD | -22.62% |
| 2012 FY | 3.88 Million USD | 36.23% |
| 2012 Q1 | 852.19 Thousand USD | 24.28% |
| 2011 FY | 2.84 Million USD | 37.77% |
| 2011 Q1 | 498.35 Thousand USD | -9.85% |
| 2011 Q2 | 621.82 Thousand USD | 24.77% |
| 2011 Q3 | 690.26 Thousand USD | 11.01% |
| 2011 Q4 | 685.69 Thousand USD | -0.66% |
| 2010 Q2 | 483.51 Thousand USD | 4.99% |
| 2010 FY | 2.06 Million USD | 15.57% |
| 2010 Q4 | 552.8 Thousand USD | 3.51% |
| 2010 Q1 | 460.53 Thousand USD | -3.96% |
| 2010 Q3 | 534.03 Thousand USD | 10.45% |
| 2009 Q4 | 479.51 Thousand USD | 7.0% |
| 2009 FY | 1.78 Million USD | 26.35% |
| 2009 Q1 | 423.15 Thousand USD | 24.44% |
| 2009 Q3 | 448.12 Thousand USD | 11.54% |
| 2009 Q2 | 401.77 Thousand USD | -5.05% |
| 2008 Q2 | 374.87 Thousand USD | 25.03% |
| 2008 Q1 | 299.82 Thousand USD | -4.46% |
| 2008 FY | 1.41 Million USD | 12.96% |
| 2008 Q4 | 340.04 Thousand USD | 5.97% |
| 2008 Q3 | 320.89 Thousand USD | -14.4% |
| 2007 FY | 1.25 Million USD | 14.73% |
| 2007 Q3 | 346.31 Thousand USD | 18.88% |
| 2007 Q4 | 313.82 Thousand USD | -9.38% |
| 2007 Q2 | 291.31 Thousand USD | -1.07% |
| 2007 Q1 | 294.46 Thousand USD | 26.98% |
| 2006 Q1 | 340.48 Thousand USD | 34.56% |
| 2006 Q3 | 251.62 Thousand USD | -20.17% |
| 2006 Q4 | 231.9 Thousand USD | -7.84% |
| 2006 FY | 1.09 Million USD | -1.12% |
| 2006 Q2 | 315.21 Thousand USD | -7.42% |
| 2005 Q2 | 333.41 Thousand USD | -5.06% |
| 2005 FY | 1.1 Million USD | -7.34% |
| 2005 Q4 | 253.04 Thousand USD | -6.9% |
| 2005 Q3 | 271.78 Thousand USD | -18.48% |
| 2005 Q1 | 351.16 Thousand USD | 21.18% |
| 2004 FY | 1.19 Million USD | 13.58% |
| 2004 Q2 | 275.19 Thousand USD | 2.03% |
| 2004 Q3 | 276.96 Thousand USD | 0.64% |
| 2004 Q4 | 289.78 Thousand USD | 4.63% |
| 2004 Q1 | 269.71 Thousand USD | 0.61% |
| 2003 Q1 | 467.36 Thousand USD | 201.09% |
| 2003 FY | 1.05 Million USD | 10.63% |
| 2003 Q4 | 268.06 Thousand USD | 2.18% |
| 2003 Q3 | 262.33 Thousand USD | 4.79% |
| 2003 Q2 | 250.35 Thousand USD | -46.43% |
| 2002 FY | 949.57 Thousand USD | 18.37% |
| 2002 Q4 | 155.22 Thousand USD | -2.86% |
| 2002 Q3 | 159.8 Thousand USD | -3.48% |
| 2002 Q2 | 165.56 Thousand USD | -12.2% |
| 2002 Q1 | 188.56 Thousand USD | -5.06% |
| 2001 Q1 | 394.06 Thousand USD | 75.97% |
| 2001 FY | 802.2 Thousand USD | -25.81% |
| 2001 Q4 | 198.61 Thousand USD | -0.43% |
| 2001 Q3 | 199.46 Thousand USD | -7.47% |
| 2001 Q2 | 215.56 Thousand USD | -45.3% |
| 2000 FY | 1.08 Million USD | -8.15% |
| 2000 Q2 | 212.41 Thousand USD | 0.0% |
| 2000 Q4 | 223.93 Thousand USD | 7.08% |
| 2000 Q3 | 209.13 Thousand USD | -1.55% |
| 1999 FY | 1.17 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 74.961% |
| AngioDynamics, Inc. | 252.41 Million USD | 89.657% |
| AtriCure, Inc. | 327.05 Million USD | 92.017% |
| Avinger, Inc. | 18.63 Million USD | -40.079% |
| Azenta, Inc. | 336.26 Million USD | 92.236% |
| BioLife Solutions, Inc. | 117.57 Million USD | 77.795% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 98.569% |
| Daxor Corporation | 1.28 Million USD | -1938.857% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | -7.924% |
| Femasys Inc. | 15.2 Million USD | -71.759% |
| GlucoTrack, Inc. | 7.1 Million USD | -267.509% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 55.433% |
| Hologic, Inc. | 1.34 Billion USD | 98.059% |
| ICU Medical, Inc. | 717.04 Million USD | 96.359% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.119% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 71.099% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 21978.899% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 21978.899% |
| Masimo Corporation | 867 Million USD | 96.989% |
| Microbot Medical Inc. | 9.85 Million USD | -164.92% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | -41.736% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 94.323% |
| Nephros, Inc. | 9.78 Million USD | -166.843% |
| NovoCure Limited | 613.92 Million USD | 95.747% |
| NEXGEL, Inc. | 4.09 Million USD | -537.399% |
| NEXGEL, Inc. | 4.09 Million USD | -537.399% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 74.465% |
| OraSure Technologies, Inc. | 125.34 Million USD | 79.171% |
| Pro-Dex, Inc. | 7.37 Million USD | -253.861% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 40.084% |
| Predictive Oncology Inc. | 15.22 Million USD | -71.429% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -206.355% |
| QuidelOrtho Corporation | 1.35 Billion USD | 98.074% |
| Repligen Corporation | 261.12 Million USD | 90.002% |
| Sanara MedTech Inc. | 61.12 Million USD | 57.289% |
| STAAR Surgical Company | 224.55 Million USD | 88.373% |
| Sharps Technology, Inc. | 10.12 Million USD | -157.814% |
| Utah Medical Products, Inc. | 13.26 Million USD | -96.877% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 98.545% |
| Jin Medical International Ltd. | 3.91 Million USD | -566.43% |